2021
DOI: 10.1002/jper.20-0718
|View full text |Cite
|
Sign up to set email alerts
|

Leukotriene receptor antagonist reduces inflammation and alveolar bone loss in a rat model of experimental periodontitis

Abstract: Background Leukotrienes (LTs) participate in the process of tissue damage in periodontal disease by leukocyte chemotaxis and osteoclastic activation. The activation of Cysteinyl‐LT receptor is associated with increased expression of proinflammatory molecules and osteoclastogenesis. However, its implications on periodontal disease progression have not been studied. The present study evaluated the effect of the cysteinyl‐LT receptor antagonist (montelukast [MT]) on ligature‐induced experimental periodontitis (EP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…Indeed, BLT antagonists have exhibited anti-inflammatory activities in multiple experimental inflammation models, such as murine pemphigoid disease [ 187 ], experimental periodontitis [ 188 ]. It is feasible to conduct structure-activity relationship studies to identify more potent antagonists to diminish inflammation caused by endogenous hypoxic.…”
Section: Targeting the Critical Mediators In Endogenous Hypoxic To Co...mentioning
confidence: 99%
“…Indeed, BLT antagonists have exhibited anti-inflammatory activities in multiple experimental inflammation models, such as murine pemphigoid disease [ 187 ], experimental periodontitis [ 188 ]. It is feasible to conduct structure-activity relationship studies to identify more potent antagonists to diminish inflammation caused by endogenous hypoxic.…”
Section: Targeting the Critical Mediators In Endogenous Hypoxic To Co...mentioning
confidence: 99%